MetrioPharm Publishes First Trial Data Showing Effects of Host-Directed Therapy in COVID-19

Results of clinical trial CT-05 in 131 hospitalized patients with COVID-19Trial data demonstrate that MetrioPharm´s lead compound MP1032 has comparable efficacy to remdesivir with several additional benefitsResults have been published

Related Keywords

Zurich ,Züsz ,Switzerland ,Berlin ,Germany ,Swiss ,Wolfgang Brysch ,Ludger Wess Ines Regina Buth ,Thomas Christ ,Lancet Regional Health ,Response Authority ,Neither The European Union ,European Union Or Commission ,Corporate Communications ,European Union ,European Commission ,European Union Horizon Europe ,European Health Emergency Preparedness ,Long Covid ,Horizon Europe ,Ludger Wess ,Business ,